XBiotech Inc. (XBIT)

4.3600 -0.2000 (-4.39%) At close: 03:59PM EDT

XBiotech Inc.

5217 Winnebago Lane
Austin, TX 78744
United States
512 386 2900
https://www.xbiotech.com

Sector(s): Healthcare
Industry: Biotechnology
Full Time Employees: 84

Key Executives

Name	Title	Pay	Exercised	Year Born
Mr. John Simard	Founder, Pres, CEO & Chairman	4.67M	N/A	1962
Dr. Sushma Shivaswamy Ph.D.	Chief Scientific Officer	381.24k	N/A	1978
Ms. Angela Hu	Director of Fin., Principal Financial & Accounting Officer and Financial Controller	N/A	N/A	1984

Amounts are as of December 31, 2022 and compensation values are for the last fiscal year ending on that date. Pay is salary, bonuses, etc. Exercised is the value of options exercised during the fiscal year. Currency in USD.

Description

XBiotech Inc., a biopharmaceutical company, discovers, develops, and commercializes True Human monoclonal antibodies for treating various diseases. The company focuses on developing a pipeline of product candidates targeting both inflammatory and infectious diseases. It is also developing interleukin-1 alpha therapies to treat variety of medical conditions, such as cancer, stroke, heart attack, or arthritis; and mediates tissue breakdown, angiogenesis, the formation of blood clots, malaise, muscle wasting, and inflammation. The company was incorporated in 2005 and is headquartered in Austin, Texas.

Corporate Governance

XBiotech Inc.’s ISS Governance QualityScore as of September 1, 2023 is 8. The pillar scores are Audit: 9; Board: 7; Shareholder Rights: 5; Compensation: 9.

Corporate governance scores courtesy of Institutional Shareholder Services (ISS). Scores indicate decile rank relative to index or region. A decile score of 1 indicates lower governance risk, while a 10 indicates higher governance risk.